{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:58:37Z","timestamp":1791874717275,"version":"4.3.4"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Although the vast majority of cancers affecting the human pancreas are pancreatic ductal adenocarcinomas (PDAC), there are several other cancer types originating from non-exocrine cells of this organ, <jats:italic>i.e.<\/jats:italic>, pancreatic neuroendocrine tumors (panNET). Genomic analyses of PDAC and panNET revealed that certain signaling pathways such as those triggered by transforming growth factor-\u03b2 (TGF-\u03b2) are frequently altered, highlighting their crucial role in pancreatic tumor development. In PDAC, TGF-\u03b2 plays a dual role acting as a tumor suppressor in healthy tissue and early stages of tumor development but as a promoter of tumor progression in later stages. This peptide growth factor acts as a potent inducer of epithelial-to-mesenchymal transition (EMT), a developmental program that transforms otherwise stationary epithelial cells to invasive mesenchymal cells with enhanced metastatic potential. TGF-\u03b2 signals through both the canonical Smad pathway involving the receptor-regulated Smad proteins, SMAD2 and SMAD3, and the common-mediator Smad, SMAD4, as well as Smad-independent pathways, <jats:italic>i.e.<\/jats:italic>, ERK1\/2, PI3K\/AKT, and somatostatin (SST). Accumulating evidence indicates an intimate crosstalk between TGF-\u03b2 and SST signaling, not only in PDAC but, more recently, also in panNET. In this work, we review the available evidence on signaling interactions between both pathways, which we believe are of potential but as yet insufficiently appreciated importance for pancreatic cancer development and\/or progression as well as novel therapeutic approaches.<\/jats:p>","DOI":"10.3389\/fendo.2025.1511348","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:01:03Z","timestamp":1741705263000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Crosstalk of TGF-\u03b2 and somatostatin signaling in adenocarcinoma and neuroendocrine tumors of the pancreas: a brief review"],"prefix":"10.3389","volume":"16","author":[{"given":"Hendrik","family":"Ungefroren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpal","family":"Randeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Uwe","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Konukiewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Hass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2021.06.003","article-title":"Pathology and molecular characteristics of pancreatic cancer","volume":"30","author":"Kearney","year":"2021","journal-title":"Surg Oncol Clin N Am"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2024.2357802","article-title":"The trend toward more target therapy in pancreatic ductal adenocarcinoma. Expert Rev","volume":"24","author":"Deiana","year":"2024","journal-title":"Anticancer Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036094","article-title":"A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment","volume":"102","author":"Alshareefy","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.012.10295","article-title":"Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment","volume":"32","author":"Ro","year":"2013","journal-title":"Chin J Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-3144265","article-title":"Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma","volume":"68","author":"Lee","year":"2019","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12964-017-0175-0","article-title":"The role of TGF-\u03b2 and its crosstalk with RAC1\/RAC1b signaling in breast and pancreas carcinoma","volume":"15","author":"Melzer","year":"2017","journal-title":"Cell Commun Signal"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071574","article-title":"TGF-beta-dependent growth arrest and cell migration in benign and Malignant breast epithelial cells are antagonistically controlled by Rac1 and Rac1b","volume":"18","author":"Melzer","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010021","article-title":"Rac1b, a Rho GTPase with versatile functions in Malignant transformation and tumor progression","volume":"8","author":"Melzer","year":"2019","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.24976\/Discov.Med.202335179.105","article-title":"Somatostatin inhibited the EMT of pancreatic cancer cells by mediating the TGF-beta\/smad signaling pathway","volume":"35","author":"Zhou","year":"2023","journal-title":"Discovery Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011017","article-title":"Molecular basis of pancreatic neuroendocrine tumors","volume":"25","author":"Maluchenko","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2017.10.08","article-title":"Management of functional neuroendocrine tumors of the pancreas","volume":"7","author":"\u00d6berg","year":"2018","journal-title":"Gland Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010436","article-title":"Somatostatin and somatostatin receptors in tumour biology","volume":"25","author":"Kumar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.2627","article-title":"American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants","volume":"27","author":"Hensley","year":"2009","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Electronic address: clinicalguidelines@esmo.org Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202118","article-title":"Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells","volume":"17","author":"Villanueva","year":"1998","journal-title":"Oncogene"},{"key":"B18","article-title":"Expression of transforming growth factors beta 1, beta 2, beta 3 in neuroendocrine tumors of the digestive system","volume":"14","author":"Chaudhry","year":"1994","journal-title":"Anticancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000209330","article-title":"KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model","volume":"89","author":"Siddique","year":"2009","journal-title":"Neuroendocrinology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030691","article-title":"A comprehensive molecular characterization of the pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1","volume":"12","author":"Luley","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1158\/1541-7786.MCR-17-0163","article-title":"Establishment of the first well-differentiated human pancreatic neuroendocrine tumor model","volume":"16","author":"Benten","year":"2018","journal-title":"Mol Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415868","article-title":"Differential effects of somatostatin, octreotide, and lanreotide on neuroendocrine differentiation and proliferation in established and primary NET cell lines: possible crosstalk with TGF-\u03b2 Signaling","volume":"23","author":"Ungefroren","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-022-01110-x","article-title":"Immunophenotypic and molecular characterization of pancreatic neuroendocrine tumors producing serotonin","volume":"35","author":"Depoilly","year":"2022","journal-title":"Modern Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2004.03.006","article-title":"Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR","volume":"119","author":"Li","year":"2004","journal-title":"J Surg Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7814-5","article-title":"Somatostatin, somatostatin receptors, and pancreatic cancer","volume":"29","author":"Li","year":"2005","journal-title":"World J Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1998.00397.x","article-title":"Growth factor\u00a0receptor expression in human gastroenteropancreatic neuroendocrine tumours","volume":"28","author":"Wulbrand","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-199911000-00008","article-title":"Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer","volume":"19","author":"Wagner","year":"1999","journal-title":"Pancreas"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.13.7495","article-title":"Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells","volume":"273","author":"Kleeff","year":"1998","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-199905000-00006","article-title":"Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells","volume":"18","author":"Kleeff","year":"1999","journal-title":"Pancreas"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210272","article-title":"Dissecting the role of TGF-beta type I receptor\/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function","volume":"26","author":"Schniewind","year":"2007","journal-title":"Oncogene"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19960717)67:2<283::AID-IJC21>3.0.CO;2-B","article-title":"Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition","volume":"67","author":"Baldwin","year":"1996","journal-title":"Int J Cancer"},{"key":"B32","article-title":"Signal transduction in human pancreatic cancer: roles of transforming growth factor beta, somatostatin receptors, and other signal intermediates","volume":"53","author":"Li","year":"2005","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010116","article-title":"The role of receptor-ligand interaction in somatostatin signaling pathways: implications for neuroendocrine tumors","volume":"16","author":"Milewska-Kranc","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5120111.31","article-title":"Proteinase-activated receptor 2 is a novel regulator of TGF-\u03b2 Signaling in pancreatic cancer","volume":"5","author":"Witte","year":"2016","journal-title":"J Clin Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123674","article-title":"The intimate relationship among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to be exploited for therapeutic purposes","volume":"12","author":"Hass","year":"2020","journal-title":"Cancers Basel)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082107","article-title":"Role of MSC in the tumor microenvironment","volume":"12","author":"Hass","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123716","article-title":"Impact of the tumor microenvironment on tumor heterogeneity and consequences for cancer cell plasticity and stemness","volume":"12","author":"Hass","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12964-024-01886-2","article-title":"Human mesenchymal stroma\/stem-like cell-derived taxol-loaded EVs\/exosomes transfer anti-tumor microRNA signatures and express enhanced SDF-1-mediated tumor tropism","volume":"22","author":"Hass","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-07-2073","article-title":"The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling","volume":"6","author":"Leu","year":"2008","journal-title":"Mol Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2005.05.005","article-title":"Midgut carcinoid tumours: surgical treatment and prognosis","volume":"19","author":"Kerstr\u00f6m","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048411","article-title":"The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells","volume":"7","author":"Li","year":"2012","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30360","article-title":"TGF-\u03b21\/Smad2\/3 signaling pathway modulates octreotide antisecretory and antiproliferative effects in pituitary somatotroph tumor cells","volume":"236","author":"Picech","year":"2021","journal-title":"J Cell Physiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010981200","article-title":"Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-beta. Involvement of Smad4","volume":"276","author":"Puente","year":"2001","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/156720111793663633","article-title":"Somatostatin receptor-targeted anti-cancer therapy","volume":"8","author":"Sun","year":"2011","journal-title":"Curr Drug Delivery"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.02.009","article-title":"Loss of somatostatin receptor subtype 2 promotes growth of KRAS-induced pancreatic tumors in mice by activating PI3K signaling and overexpression of CXCL16","volume":"148","author":"Chalabi-Dchar","year":"2015","journal-title":"Gastroenterology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/cells13232010","article-title":"R. Characterization of epithelial-mesenchymal and neuroendocrine differentiation states in pancreatic and small cell ovarian tumor cells and their modulation by TGF-\u03b21 and BMP-7","volume":"13","author":"Ungefroren","year":"2024","journal-title":"Cells"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.130196697","article-title":"Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238","volume":"97","author":"Benali","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/BF02828041","article-title":"Inhibition of metastatic progression of SSTR2 gene transfection mediated by adenovirus in human pancreatic carcinoma cells","volume":"26","author":"Feng","year":"2006","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3892\/or_00000579","article-title":"hSSTR2 expression and octreotide treatment reverses multidrug resistance of BxPC-3 human pancreatic cancer cells","volume":"22","author":"Sui","year":"2009","journal-title":"Oncol Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0030","article-title":"Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines","volume":"64","author":"Tian","year":"2004","journal-title":"Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.18.8108-8125.2005","article-title":"Smad4 dependency defines two classes of transforming growth\u00a0factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses","volume":"25","author":"Levy","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.029025","article-title":"Inhibition of\u00a0transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness","volume":"72","author":"Gaspar","year":"2007","journal-title":"Mol Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2005.16.1175","article-title":"Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells","volume":"16","author":"Carrere","year":"2005","journal-title":"Hum Gene Ther"},{"key":"B54","article-title":"Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models","volume":"62","author":"Vernejoul","year":"2002","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/s1535-6108(03)00309-x","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1475506","article-title":"Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression","volume":"20","author":"Ijichi","year":"2006","journal-title":"Genes Dev"},{"key":"B57","article-title":"Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation","volume":"7","author":"Rowland-Goldsmith","year":"2001","journal-title":"Clin Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","article-title":"EMT subtype influences epithelial plasticity and mode of cell migration","volume":"45","author":"Aiello","year":"2018","journal-title":"Dev Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1013","article-title":"SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo","volume":"64","author":"Uhl","year":"2004","journal-title":"Cancer Res"},{"key":"B60","article-title":"Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment","volume":"27","author":"Medicherla","year":"2007","journal-title":"Anticancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/1874467211104020096","article-title":"Radiation induced non-targeted response: mechanism and potential clinical implications","volume":"4","author":"Hei","year":"2011","journal-title":"Curr Mol Pharmacol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1089\/10430349950018391","article-title":"Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer","volume":"10","author":"Rochaix","year":"1999","journal-title":"Hum Gene Ther"},{"key":"B63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13046-022-02471-6","article-title":"Irradiation induces DJ-1 secretion from esophageal squamous cell carcinoma cells to accelerate metastasis of bystander cells via a TGF-beta1 positive feedback loop","volume":"41","author":"Gu","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4161\/rna.34345","article-title":"MiR-663 inhibits radiation-induced bystander effects by targeting TGFB1 in a feedback mode","volume":"11","author":"Hu","year":"2014","journal-title":"RNA Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3967\/bes2022.059","article-title":"MiR-663a inhibits radiation-induced epithelium-to-mesenchymal transition by targeting TGF-beta1","volume":"35","author":"Qu","year":"2022","journal-title":"BioMed Environ Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s1359-6101(99)00029-5","article-title":"Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology","volume":"11","author":"Murphy-Ullrich","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.368","article-title":"The role of TGF-beta1-miR-21-ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells","volume":"111","author":"Jiang","year":"2014","journal-title":"Br J Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/srep11373","article-title":"Radiation quality-dependence of bystander effect in unirradiated fibroblasts is associated with TGF-beta1-Smad2 pathway and miR-21 in irradiated keratinocytes","volume":"5","author":"Yin","year":"2015","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210653","article-title":"Role of TGF-beta1 and nitric oxide in the bystander response of irradiated glioma cells","volume":"27","author":"Shao","year":"2008","journal-title":"Oncogene"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.53","article-title":"Radiation-induced non-targeted response in vivo: role of the TGF\u03b2-TGFBR1-COX-2 signalling pathway","volume":"108","author":"Chai","year":"2013","journal-title":"Br J Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mrfmmm.2004.06.049","article-title":"IR-inducible clusterin gene expression: a protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects","volume":"568","author":"Klokov","year":"2004","journal-title":"Mutat Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111046","article-title":"Recent progress in TGF-beta inhibitors for cancer therapy","volume":"134","author":"Huang","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104380","article-title":"The difficulty in translating the preclinical success of combined TGFbeta and immune checkpoint inhibition to clinical trial","volume":"86","author":"Metropulos","year":"2022","journal-title":"EbioMedicine"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2022.1610196","article-title":"Somatostatin receptor 2: A potential predictive biomarker for immune checkpoint inhibitor treatment","volume":"28","author":"Wang","year":"2022","journal-title":"Pathol Oncol Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.10.007","article-title":"Inhibitory effect of pasireotide and octreotide on lymphocyte activation","volume":"182","author":"Lattuada","year":"2007","journal-title":"Neuroimmunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1322670","article-title":"Somatostatin-SSTR3-GSK3 modulates human T-cell responses by inhibiting OXPHOS","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.665161","article-title":"An EMT-related gene signature for predicting response to adjuvant chemotherapy in pancreatic ductal adenocarcinoma","volume":"9","author":"Feng","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101317","article-title":"Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma","volume":"17","author":"Ge","year":"2022","journal-title":"Transl Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.08.005","article-title":"Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt\/beta-catenin signaling pathway, c-Myc and cyclin D1","volume":"63","author":"Zhang","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1097\/01.alc.0000189284.98684.22","article-title":"Anti-TGF-beta strategies for the treatment of chronic liver disease","volume":"29","author":"Breitkopf","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2009.11.008","article-title":"Effect of somatostatin analog on high-fat diet-induced metabolic syndrome: involvement of reactive oxygen species","volume":"31","author":"Li","year":"2010","journal-title":"Peptides"},{"key":"B82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mce.2008.02.008","article-title":"Novel signals mediating the functions of somatostatin: the emerging role of NO\/cGMP","volume":"286","author":"Thermos","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2011.43.3.181","article-title":"Clinical significance of protein expression of cyclooxygenase-2 and somatostatin receptors in gastroenteropancreatic neuroendocrine tumors","volume":"43","author":"Kim","year":"2011","journal-title":"Cancer Res Treat"},{"key":"B84","doi-asserted-by":"publisher","first-page":"11033","DOI":"10.1038\/s41598-018-29349-y","article-title":"Cyclooxygenase-2 up-regulates hepatic somatostatin receptor 2 expression","volume":"8","author":"Lu","year":"2018","journal-title":"Sci Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/bjp.2008.268","article-title":"Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation","volume":"155","author":"Colucci","year":"2008","journal-title":"Br J Pharmacol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1511348\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:01:11Z","timestamp":1741705271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1511348\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":85,"alternative-id":["10.3389\/fendo.2025.1511348"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1511348","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"article-number":"1511348"}}